Cargando…

R&D for Emerging Infectious Diseases of Epidemic Potential: Sharing Risks and Benefits Through a New Coalition

The lack of effective vaccines for emerging infectious diseases (EID) of limited market potential, such as Chikungunya and Zika, poses a serious threat to human life and prosperity. Research and development (R&D) for new vaccines for EIDs faces two major challenges. The first is R&D prepared...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopinathan, Unni, Peacocke, Elizabeth, Gouglas, Dimitrios, Ottersen, Trygve, Røttingen, John-Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226903/
http://dx.doi.org/10.1007/978-3-030-39819-4_7